Amarin Plcuk (AMRN) Gross Profit Margin starting from the second quarter 2026 to second quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Amarin Corp Plcuk  (NASDAQ: AMRN)


Amarin Plcuk's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AMRN Gross Profit Margin (Jun 30 2026)
Q2 		(Mar 31 2026)
Q1 		(Dec 31 2025)
Q4 		(Sep 30 2025)
Q3 		(Jun 30 2025)
Q2
Y / Y Revenue Change -41.63 %
Seq. Revenue Change -5.92 %
Revenue In Millions $42.46
Gross Profit Margin 35.3 %
Gross Profit Margin Total Ranking # 2110
Gross Profit In Millions $14.99
Y / Y Gross Profit Change -70.24 %
Seq. Gross Profit Change -15.65 %


Commenting Second Quarter 2026 Gross Profit Margin
Amarin Corp Plcuk experienced contraction in Gross Profit by -15.65 % to $42 millions and Revenue by -5.92 %, while Gross Profit Margin fell to 35.3 % a new company low.


Observing second quarter 2026 results within Major Pharmaceutical Preparations industry 123 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 1960 to 2110.
Learn about Gross Margin
AMRN's Gross Profit Margin second quarter 2026 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 124
Healthcare Sector # 355
Overall # 2092

Gross Profit Margin Statistics
High Average Low
100 % 66.89 % 35.3 %
(Mar 31 2023)   (Jun 30 2026)


AMRN Gross Income Trends • More of AMRN's Profitabilty Ratios • AMRN Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
AMRN's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
AMRN's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for AMRN's Competitors
Gross Profit Margin Profit Margin for Amarin Plcuk's Suppliers
Gross Profit Margin Profit Margin for AMRN's Customers

You may also want to know
AMRN's Annual Growth Rates AMRN's Profitability Ratios AMRN's Asset Turnover Ratio AMRN's Dividend Growth
AMRN's Roe AMRN's Valuation Ratios AMRN's Financial Strength Ratios AMRN's Gross Profit Growth
AMRN's Roa AMRN's Inventory Turnover Ratio AMRN's Growth Rates AMRN's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2026, within Major Pharmaceutical Preparations Industry Gross Profit MarginJun 30 2026 MRQ Gross ProfitJun 30 2026 MRQ Revenue
Zevra Therapeutics Inc   96.16 %$ 38.138  Millions$ 39.663  Millions
Ardelyx inc   95.24 %$ 115.118  Millions$ 120.877  Millions
Tonix Pharmaceuticals Holding Corp   94.81 %$ 12.841  Millions$ 13.544  Millions
Lexicon Pharmaceuticals Inc   94.36 %$ 0.653  Millions$ 0.692  Millions
Milestone Pharmaceuticals Inc   94.28 %$ 0.527  Millions$ 0.559  Millions
Bridgebio Pharma Inc   93.83 %$ 228.630  Millions$ 243.676  Millions
Axsome Therapeutics Inc   93.79 %$ 204.811  Millions$ 218.375  Millions
Agios Pharmaceuticals Inc   93.30 %$ 41.749  Millions$ 44.745  Millions
Vanda Pharmaceuticals Inc   92.95 %$ 46.969  Millions$ 50.529  Millions
Gyre Therapeutics Inc   92.41 %$ 26.896  Millions$ 29.105  Millions
Aurinia Pharmaceuticals Inc   92.12 %$ 76.665  Millions$ 83.220  Millions
Arcutis Biotherapeutics Inc   91.58 %$ 118.922  Millions$ 129.861  Millions
Urogen Pharma Ltd   90.93 %$ 65.884  Millions$ 72.456  Millions
Acadia Pharmaceuticals Inc   90.81 %$ 279.643  Millions$ 307.959  Millions
Cytokinetics Incorporated  90.46 %$ 25.893  Millions$ 28.624  Millions
Beone Medicines Ltd   89.76 %$ 1,530.541  Millions$ 1,705.071  Millions
Rigel Pharmaceuticals Inc  89.17 %$ 70.178  Millions$ 78.703  Millions
Bioxcel Therapeutics Inc   87.91 %$ 0.160  Millions$ 0.182  Millions
Rhythm Pharmaceuticals Inc   87.47 %$ 62.324  Millions$ 71.255  Millions
United Therapeutics Corporation  87.30 %$ 683.800  Millions$ 783.300  Millions
Ligand Pharmaceuticals Incorporated  87.29 %$ 55.596  Millions$ 63.693  Millions
Jupiter Neurosciences Inc   86.88 %$ 0.021  Millions$ 0.024  Millions
Mannkind Corporation  86.83 %$ 94.965  Millions$ 109.374  Millions
Aclaris Therapeutics Inc   86.62 %$ 1.411  Millions$ 1.629  Millions
Regeneron Pharmaceuticals Inc   86.56 %$ 3,714.200  Millions$ 4,290.700  Millions
Xeris Biopharma Holdings Inc   86.41 %$ 79.588  Millions$ 92.100  Millions
Eli Lilly And Company  85.78 %$ 19,706.000  Millions$ 22,974.000  Millions
Cormedix Inc   85.77 %$ 87.426  Millions$ 101.931  Millions
Indivior Pharmaceuticals Inc   85.71 %$ 294.000  Millions$ 343.000  Millions
Vertex Pharmaceuticals Inc  85.33 %$ 2,844.700  Millions$ 3,333.900  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.